Pulse Biosciences (PLSE) Total Debt (2021 - 2023)

Pulse Biosciences has reported Total Debt for 3 years, with the latest figure at $65.8 million in Q1 2023.

• On a quarterly basis, Total Debt changed N/A year-over-year to $65.8 million in Q1 2023; TTM through Mar 2023 was $65.8 million, a N/A change from a year earlier, with the FY2022 full-year figure at $65.9 million, up 15018.58% from the prior year.
• Total Debt was $65.8 million for Q1 2023 at Pulse Biosciences, roughly flat from $65.9 million in the prior quarter.
• The five-year high for Total Debt was $65.9 million in Q4 2022, with the low at $436000.0 in Q4 2021.
• Average Total Debt over 3 years is $34.5 million, with a median of $41.1 million recorded in 2021.
• The largest YoY upside for Total Debt was 15018.58% in 2022 against a maximum downside of 5894.29% in 2022.
• Over 3 years, Total Debt stood at $436000.0 in 2021, then soared by 15018.58% to $65.9 million in 2022, then fell by 0.18% to $65.8 million in 2023.
• The last three Total Debt figures came in at $65.8 million (Q1 2023), $65.9 million (Q4 2022), and $65.1 million (Q3 2022), per Business Quant data.